AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity

RecruitingNAAges 1 Year - 18 YearsAllUniversity of Utah
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Children with medical complexity (CMC) are the most vulnerable of children with chronic diseases, who have complex, multisystem chronic diseases affecting โ‰ฅ3 organ systems, severe functional limitations and technology dependencies. CMC have high health care needs, and account for 40% of hospitalized children and 35% of all pediatric health care costs. Due to high medical fragility, CMC have frequent acute deteriorations superimposed on their chronic conditions, leading to recurrent emergency department (ED)/hospital admissions and affecting quality of life (QOL). To reduce ED/hospital admissions for CMC, remote monitoring is suggested, with use of mHealth apps to regularly assess their health status remotely and identify early signs of acute deterioration, allowing for early interventions to prevent ED/hospital admissions. Yet no app to support remote monitoring of CMC exists. Variable,

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * CMC, ages 1-18 years and their parents (or primary caregivers) * CMC (inpatients or outpatients) who receive care at participating sites (comprehensive care clinics for CMC) * Own (or provided) a smartphone or tablet with internet access * Speak English or Spanish. * CMCs are identified using an operational definition, as having: 1) multisystem chronic diseases involving โ‰ฅ3 organ systems, 2) โ‰ฅ3 HCPs involved in their care, 3) high fragility or frequent (โ‰ฅ2) or 1 prolonged (\>10 days) hospitalization in the prior year, and/or 4) medical technology dependence. Exclusion Criteria: * Critically ill CMC and infants. * CMC exhibit similar developmental and functional abilities and typically function below expected for a 7-year-old child, allowing inclusion of a wide age range in studies. * Infants were excluded as many CMC \<1 year have prematurity-related conditions that may resolve by age 2. * CMC \>18 years of age were not included as some may transition to adult health care. * Note: No one will be excluded due to lack of smartphone/internet access. We estimated \<10% of families may not have a smartphone/internet, and will provide them low-cost tablets and cellular internet access.
๐Ÿ’Š

What it tests

  • MyChildCMC app (an app designed to facilitate home monitoring of CMC's health status)
๐Ÿ“

Where

2 sites
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, United States
Primary Children's Hospital
Salt Lake City, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy